Glen Eagle Advisors’s Opko Health OPK Stock Holding History

Glen Eagle Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-250	Closed	-$1.01K	–	1086
2021 Q2	$1.01K	Hold	250	–	–	﹤0.01%	972
2021 Q1	$1.07K	Hold	250	–	–	﹤0.01%	941
2020 Q4	$988	Hold	250	–	–	﹤0.01%	909
2020 Q3	$923	Hold	250	–	–	﹤0.01%	858
2020 Q2	$853	Hold	250	–	–	﹤0.01%	828
2020 Q1	$335	Hold	250	–	–	﹤0.01%	801
2019 Q4	$368	Hold	250	–	–	﹤0.01%	871
2019 Q3	$523	Hold	250	–	–	﹤0.01%	777
2019 Q2	$610	Hold	250	–	–	﹤0.01%	757
2019 Q1	$653	Hold	250	–	–	﹤0.01%	717
2018 Q4	$753	Hold	250	–	–	﹤0.01%	691
2018 Q3	$865	Hold	250	–	–	﹤0.01%	682
2018 Q2	$1.18K	Hold	250	–	–	﹤0.01%	645
2018 Q1	$793	Buy	250 +150	+150%	+$604	﹤0.01%	652
2017 Q4	$490	Sell	100 -100	-50%	-$580	﹤0.01%	625
2017 Q3	$1.37K	Sell	200 -200	-50%	-$1.26K	﹤0.01%	595
2017 Q2	$2.63K	Hold	400	–	–	﹤0.01%	526
2017 Q1	$3.2K	Buy	400 +200	+100%	+$1.68K	﹤0.01%	490
2016 Q4	$1.86K	Buy	+200	New	+$2.07K	﹤0.01%	496

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Glen Eagle Advisors's OPK Position: Q3 2021 in Review

Glen Eagle Advisors sold out of Opko Health (OPK) in Q3 2021, closing a stake of 250 shares — an estimated $1.01K sold.

Glen Eagle Advisors first reported a position in OPK in Q4 2016 and held it in 19 quarters. The position peaked at $3.2K in Q1 2017. 206 funds tracked by Wall St. Rank hold OPK as of Q3 2021.

Glen Eagle Advisors reported no remaining Opko Health position as of Q3 2021 after selling out during the quarter.
Glen Eagle Advisors sold 250 Opko Health shares in Q3 2021, an estimated $1.01K.
Glen Eagle Advisors first reported a position in Opko Health in Q4 2016 and held it in 19 quarters.
Glen Eagle Advisors's Opko Health position peaked at $3.2K in Q1 2017.
206 funds tracked by Wall St. Rank held Opko Health as of Q3 2021.

Based on Glen Eagle Advisors's 13F filing for Q3 2021, filed 13 Aug 2024.